US President Donald Trump puts 100pc tariff on some pharmaceuticals
Donald Trump has pulled the trigger on a longstanding threat to impose a 100 per cent tariff on…
No medicine supply issues for private hospitals despite Middle East war
PETALING JAYA: Private hospitals in the country are not experiencing any disruptions in the supply of medications despite…
GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?
Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
Hundreds of ‘toxic’ poppies stolen from Victorian farm triggers health department alert
About 1,700 poppy plants grown for the pharmaceutical industry have been stolen from a regional property north-west of…
Sumitomo Pharma Shares Drop After Stem-Therapy Backing
Sumitomo Pharma Co. shares declined after a Japanese government panel endorsed a conditional approval for its regenerative therapy,…
New adrenaline nasal spray a 30-year first for Australia
The first nasal spray version of adrenaline is about to arrive in Australia, costing $194 for a two-pack. Branded…
Pura Collagen enters GLP-1 market with ‘pure’ hormone stimulating alternative
The two innovations expand the startup’s product line to seven, indicating the depth of consideration that goes into…
GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications
Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust NASHVILLE, Tenn., December 4, 2025 (Newswire.com)…
Health-Care Earnings Top S&P 500 on Strong Drug, Hospital Demand
The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty…
European Obesity Stocks Join Healthcare Rally as AI Trade Ebbs
European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from…
Why US Drug Prices Are So High. Can Trump Really Cut Them?
Americans spend more on prescription drugs than anyone else in the world. It’s true that they take a…
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.com
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid Bloomberg.comNovo Nordisk bids $9bn for obesity drug maker Metsera…